AAAAAA
Results:
1-20
|
Results: 20
Authors:
Kruis, W
Citation: W. Kruis, European guidelines for the use of anti-tumour necrosis factor agents in inflammatory bowel disease, INT J COL R, 16(1), 2001, pp. 12-13
Authors:
Stange, EF
Riemann, J
von Herbay, A
Lochs, H
Fleig, WE
Scholmerich, J
Kruis, W
Porschen, R
Bruch, HP
Zeitz, M
Schreiber, S
Moser, G
Matthes, H
Selbmann, HK
Goebell, H
Caspary, WF
Citation: Ef. Stange et al., Diagnosis and therapy of ulcerative colitis - results of an evidence-basedConsensus conference of the German Society of Gastroenterology and Metabolic Diseases, Z GASTROENT, 39(1), 2001, pp. 19
Authors:
Holtmann, G
Gschossmann, J
Kruis, W
Citation: G. Holtmann et al., Irritable bowel syndrome - Utility of current laxatives, INTERNIST, 42(4), 2001, pp. 524
Authors:
Kruis, W
Schreiber, S
Theuer, D
Brandes, JW
Schutz, E
Howaldt, S
Krakamp, B
Hamling, J
Monnikes, H
Koop, I
Stolte, M
Pallant, D
Ewald, U
Citation: W. Kruis et al., Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three timesdaily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses, GUT, 49(6), 2001, pp. 783-789
Authors:
Schreiber, S
Nikolaus, S
Malchow, H
Kruis, W
Lochs, H
Raedler, A
Hahn, EG
Krummenerl, T
Steinmann, G
Citation: S. Schreiber et al., Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease, GASTROENTY, 120(6), 2001, pp. 1339-1346
Authors:
Kruis, W
Citation: W. Kruis, Cholangitis in ulcerative colitis - a risk factor for colonic malignancy?, INT J COL R, 15(3), 2000, pp. 172-172
Authors:
Pohl, C
Hombach, A
Kruis, W
Citation: C. Pohl et al., Chronic inflammatory bowel disease and cancer, HEP-GASTRO, 47(31), 2000, pp. 57-70
Authors:
Hampe, J
Heymann, K
Kruis, W
Raedler, A
Folsch, UR
Schreiber, S
Citation: J. Hampe et al., Anticipation in inflammatory bowel disease: A phenomenon caused by an accumulation of confounders, AM J MED G, 92(3), 2000, pp. 178-183
Authors:
Allgayer, H
Tillmann, T
Hombach, A
Kruis, W
Pohl, C
Citation: H. Allgayer et al., Aminosalicylates and aspirin for colonic cancer: From anti-inflammatory toantineoplastic drugs?, Z GASTROENT, 38(12), 2000, pp. 963-970
Authors:
Hombach, A
Schneider, C
Sent, D
Koch, D
Willemsen, RA
Diehl, V
Kruis, W
Bolhuis, RL
Pohl, C
Abken, H
Citation: A. Hombach et al., An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood T cells to specific lysis of carcinoembryonic antigen-positive tumor cells, INT J CANC, 88(1), 2000, pp. 115-120
Authors:
Bantel, H
Berg, C
Vieth, M
Stolte, M
Kruis, W
Schulze-Osthoff, K
Citation: H. Bantel et al., Mesalazine inhibits activation of transcription factor NF-kappa B in inflamed mucosa of patients with ulcerative colitis, AM J GASTRO, 95(12), 2000, pp. 3452-3457
Authors:
Rosenbaum, A
Kruis, W
Riemann, JF
Citation: A. Rosenbaum et al., Interventional endoscopy in chronic inflammatory bowel disease, DEUT MED WO, 124(33), 1999, pp. 967-971
Authors:
Hombach, A
Koch, D
Sircar, R
Heuser, C
Diehl, V
Kruis, W
Pohl, C
Abken, H
Citation: A. Hombach et al., A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA, GENE THER, 6(2), 1999, pp. 300-304
Authors:
Kruis, W
Pohl, C
Citation: W. Kruis et C. Pohl, Clinical efficacy of different 5-ASA preparations in ulcerative colitis, MED KLIN, 94, 1999, pp. 26-29
Authors:
Lanyi, B
Dries, V
Dienes, EP
Kruis, W
Citation: B. Lanyi et al., Therapy of prednisone-refractory collagenous colitis with budesonide, INT J COL R, 14(1), 1999, pp. 58-61
Authors:
Allgayer, H
Bohne, P
Kruis, W
Citation: H. Allgayer et al., Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?, DIG DIS SCI, 44(8), 1999, pp. 1600-1600
Authors:
Allgayer, H
Kolb, M
Stuber, V
Kruis, W
Citation: H. Allgayer et al., Modulation of base hydroxylation by bile acids and salicylates in a model of human colonic mucosal DNA - Putative implications in colonic cancer, DIG DIS SCI, 44(4), 1999, pp. 761-767
Authors:
Kruis, W
Pohl, C
Citation: W. Kruis et C. Pohl, How to prevent a flare-up in ulcerative colitis, DRUGS TODAY, 35, 1999, pp. 133-138
Authors:
Allgayer, H
Pohl, C
Kruis, W
Citation: H. Allgayer et al., Arterial oxygen desaturation during endoscopic ultrasonography combined with gastroscopy: A safety evaluation in out-patients, ENDOSCOPY, 31(6), 1999, pp. 447-451
Authors:
Musch, E
Hogemann, B
Gerritzen, A
Fischer, HP
Wiese, M
Kruis, W
Malek, M
Gugler, R
Schmidt, G
Huchzermeyer, H
Gerlach, U
Dengler, HJ
Sauerbach, T
Citation: E. Musch et al., Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B, HEP-GASTRO, 45(24), 1998, pp. 2282-2294
Risultati:
1-20
|